UPDATED Apr 11, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HVO | UK£0.29 | -0.8% | 81.5% | UK£200.7m | n/a | PE12.5x | E-12.1% | n/a | Pharmaceuticals & Biotech | ||
INS | UK£8.30 | 0.3% | 23.9% | UK£199.6m | UK£10.23 | PE59.8x | S11.4% | n/a | Healthcare | ||
IDHC | US$0.37 | -1.2% | -16.1% | US$221.4m | n/a | PE20.6x | E27.9% | n/a | Healthcare | ||
AVCT | UK£0.53 | 4.0% | -59.9% | UK£149.4m | n/a | PS9.3x | E3.7% | n/a | Pharmaceuticals & Biotech | ||
AGY | UK£0.029 | -1.7% | n/a | UK£135.8m | n/a | PS2.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
CREO | UK£0.37 | 0% | 37.4% | UK£129.3m | n/a | PS4.4x | E61.1% | n/a | Healthcare | ||
ANCR | UK£2.14 | 1.9% | 12.6% | UK£128.6m | UK£2.94 | PE107.3x | E-5.6% | 2.1% | Pharmaceuticals & Biotech | ||
EKF | UK£0.28 | -6.3% | -5.0% | UK£125.9m | n/a | PE53.5x | S6.6% | 4.3% | Healthcare | ||
4BB | UK£9.50 | 2.2% | 45.0% | UK£121.6m | UK£12.00 | PS343.6x | E-11.2% | n/a | Pharmaceuticals & Biotech | ||
FUM | UK£0.36 | -7.9% | -17.2% | UK£108.5m | UK£1.26 | PS35x | S51.9% | n/a | Pharmaceuticals & Biotech | ||
KOO | UK£2.66 | -1.8% | -2.2% | UK£97.0m | UK£5.17 | PS2.9x | E26.1% | n/a | Healthcare | ||
FARN | UK£1.28 | -7.6% | -59.0% | UK£91.8m | UK£9.94 | PE-3.5x | E-1.0% | n/a | Pharmaceuticals & Biotech | ||
DXRX | UK£1.04 | -1.0% | 3.5% | UK£87.8m | UK£1.67 | PE14638.3x | E59.5% | n/a | Pharmaceuticals & Biotech | ||
SCLP | UK£0.10 | -1.5% | -50.7% | UK£82.8m | n/a | PE-8.7x | E-13.4% | n/a | Pharmaceuticals & Biotech | ||
CEL | UK£1.00 | 12.6% | -39.4% | UK£64.2m | UK£2.35 | PS3057.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
EAH | UK£0.94 | 10.0% | 0% | UK£63.3m | UK£1.85 | PB0.8x | E46.5% | 0% | Pharmaceuticals & Biotech | ||
ETX | UK£0.11 | 0.9% | -23.1% | UK£63.1m | n/a | PS185.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
SPEC | UK£0.49 | -1.0% | -51.0% | UK£49.8m | n/a | PB0.5x | E62.4% | 0% | Healthcare | ||
POLB | UK£0.099 | -5.3% | 36.8% | UK£49.3m | n/a | PB3x | E-13.8% | n/a | Pharmaceuticals & Biotech | ||
TRX | UK£0.61 | 0% | 4.2% | UK£43.3m | UK£1.20 | PS1.8x | E133.0% | n/a | Pharmaceuticals & Biotech | ||
AREC | UK£1.40 | -1.8% | -45.1% | UK£42.9m | UK£4.71 | PS12.7x | E38.1% | n/a | Pharmaceuticals & Biotech | ||
RENX | UK£0.30 | 7.1% | -67.6% | UK£36.8m | n/a | PS19.2x | E62.3% | n/a | Healthcare | ||
AGL | UK£0.14 | 12.2% | -20.3% | UK£35.8m | n/a | PS19.7x | E42.4% | n/a | Healthcare | ||
EDX | UK£0.10 | 0% | 207.7% | UK£33.4m | n/a | n/a | n/a | n/a | Healthcare |